Marc Kozin

Insider profile

Currently holds positions in Dicerna Pharmaceuticals Inc and UFP Technologies Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 95% 68% 82%
Transactions
15 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Dicerna Pharmaceuticals Inc Jan. 23, 2019 -
Lead Independent Director UFP Technologies Inc July 10, 2015 -
Independent Director Decoy Therapeutics Inc Oct. 1, 2014 - July 19, 2019
Independent Director Endocyte Inc July 25, 2012 - Dec. 21, 2018
Independent Director Tempest Therapeutics Inc Jan. 10, 2014 - Dec. 7, 2018
Independent Director Dyax Corp Oct. 16, 2012 - Jan. 22, 2016
Independent Director UFP Technologies Inc Jan. 1, 2006 - June 10, 2015
Marc Kozin's trades of UFP Technologies Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
137.86
Quantity 14,807 +19.3%
Value US$387,172
Transaction date
Sale
Price
390.46
Quantity 71,680 +1.9%
Value US$391,155
Transaction date
Proposed sale
Price
279.76
Quantity 71,995
Value US$510,023
Transaction date
Sale
Price
54.97
Quantity 600 -1.9%
Value US$32,982
Transaction date
Sale
Price
54.35
Quantity 8,466 -20.9%
Value US$460,127
Transaction date
Sale
Price
52.59
Quantity 200 -0.5%
Value US$10,518
Transaction date
Sale
Price
51.28
Quantity 234 -0.6%
Value US$12,000
Transaction date
Sale
Price
50.66
Quantity 500 -1.2%
Value US$25,330
Transaction date
Sale
Price
47.47
Quantity 1,000 -2.4%
Value US$47,470
Transaction date
Sale
Price
46.21
Quantity 1,133 -2.7%
Value US$52,356
Transaction date
Sale
Price
45.55
Quantity 2,600 -5.7%
Value US$118,430
Transaction date
Sale
Price
44.84
Quantity 200 -0.4%
Value US$8,968
Transaction date
Sale
Price
40.05
Quantity 455 -1.5%
Value US$18,223
Transaction date
Sale
Price
39.90
Quantity 3,342 -10.1%
Value US$133,346
Transaction date
Sale
Price
40.53
Quantity 1,075 -3.1%
Value US$43,570
Transaction date
Sale
Price
39.50
Quantity 1,535 -4.3%
Value US$60,632
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-27 2026-08-25
S Sale
14,807 +19.3%
137.86
US$387,172 		14,807 +19.3% 137.86 US$387,172
2026-08-27 2026-08-25
S Sale
71,680 +1.9%
390.46
US$391,155 		71,680 +1.9% 390.46 US$391,155
2026-08-25 2026-08-25
PrS Proposed sale
71,995
279.76
US$510,023 		71,995 279.76 US$510,023
2021-03-10 2021-03-08
S Sale
600 -1.9%
54.97
US$32,982 		600 -1.9% 54.97 US$32,982
2021-03-10 2021-03-08
S Sale
8,466 -20.9%
54.35
US$460,127 		8,466 -20.9% 54.35 US$460,127
2021-03-10 2021-03-08
S Sale
200 -0.5%
52.59
US$10,518 		200 -0.5% 52.59 US$10,518
2021-03-10 2021-03-08
S Sale
234 -0.6%
51.28
US$12,000 		234 -0.6% 51.28 US$12,000
2021-03-10 2021-03-08
S Sale
500 -1.2%
50.66
US$25,330 		500 -1.2% 50.66 US$25,330
2020-03-11 2020-03-10
S Sale
1,000 -2.4%
47.47
US$47,470 		1,000 -2.4% 47.47 US$47,470
2020-03-11 2020-03-10
S Sale
1,133 -2.7%
46.21
US$52,356 		1,133 -2.7% 46.21 US$52,356
2020-03-11 2020-03-10
S Sale
2,600 -5.7%
45.55
US$118,430 		2,600 -5.7% 45.55 US$118,430
2020-03-11 2020-03-10
S Sale
200 -0.4%
44.84
US$8,968 		200 -0.4% 44.84 US$8,968
2019-09-12 2019-09-11
S Sale
455 -1.5%
40.05
US$18,223 		455 -1.5% 40.05 US$18,223
2019-09-12 2019-09-11
S Sale
3,342 -10.1%
39.90
US$133,346 		3,342 -10.1% 39.90 US$133,346
2019-09-12 2019-09-10
S Sale
1,075 -3.1%
40.53
US$43,570 		1,075 -3.1% 40.53 US$43,570
2019-09-12 2019-09-10
S Sale
1,535 -4.3%
39.50
US$60,632 		1,535 -4.3% 39.50 US$60,632